Trial intelligence / Profile preview

Intraindividual comparison of intracameral Mydrane versus topical preoperative drops for mydriasis in bilateral cataract surgery

2018-002339-23Phase 4Completed

Sponsor
Medical University of Graz
Start
Sep 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label trial of Mydrane, tropicamide, phenylephrine and lidocaine in cataract (2 arms), sponsored by Medical University of Graz. Primary endpoint: Feasibility of capsulorhexis without additional pupil dilating actions. Started Sep 2019; status: completed.

02

Drugs

Mydranetropicamidephenylephrinelidocaine
03

Conditions

cataract

Beyond the preview

Go deeper on 2018-002339-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002339-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call